Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $263.1b | $157.22 | +1.0% | 73.4K |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $212.2b | $560.72 | +0.4% | 239 |
 DHR | Danaher Corporation | Precision Medicine Platforms | $137.1b | $195.48 | +0.6% | 472 |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $119.5b | $484.14 | 0.0% | 424 |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $78.2b | $759.00 | 0.0% | 135 |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $38.7b | $280.46 | 0.0% | 326 |
 WAT | Waters Corp | Precision Medicine Platforms | $36.8b | $400.20 | +1.0% | 2.8K |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $31.0b | $202.78 | 0.0% | 480 |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $27.5b | $219.12 | 0.0% | 286 |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $25.0b | $306.95 | -0.0% | 1.9K |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $21.7b | $161.11 | 0.0% | 193 |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $21.4b | $98.89 | 0.0% | 1.1K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $15.7b | $83.92 | 0.0% | 599 |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $12.9b | $111.67 | -0.5% | 574 |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $11.9b | $90.25 | 0.0% | 196 |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $11.6b | $61.30 | 0.0% | 1.2K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $11.2b | $72.28 | 0.0% | N/A |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $10.1b | $335.51 | 0.0% | 3 |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $9.8b | $123.96 | 0.0% | N/A |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $8.7b | $42.08 | -0.8% | 1.6K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $8.6b | $54.95 | 0.0% | 388 |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $8.5b | $307.25 | 0.0% | 9 |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $8.5b | $111.08 | 0.0% | 1.4K |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $8.3b | $47.10 | 0.0% | 57.9K |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $6.5b | $101.56 | 0.0% | 49 |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $6.4b | $141.97 | 0.0% | 78 |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $6.3b | $100.00 | 0.0% | 3.7K |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $6.0b | $47.74 | 0.0% | 891 |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $4.7b | $52.94 | 0.0% | 2.1K |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $4.7b | $26.31 | 0.0% | 1.3K |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.0% | 3.5M |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $4.4b | $16.38 | 0.0% | 1.7K |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $3.6b | $46.97 | 0.0% | 9 |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $3.6b | $24.64 | 0.0% | 362 |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $3.4b | $36.47 | 0.0% | 9 |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $3.1b | $43.34 | 0.0% | 594 |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $2.6b | $28.43 | 0.0% | 765 |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $2.4b | $46.76 | 0.0% | N/A |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $2.4b | $7.33 | 0.0% | 21.7K |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $2.3b | $47.39 | 0.0% | 5.3K |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $2.0b | $16.46 | 0.0% | 2.2K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $2.0b | $71.33 | 0.0% | 762 |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $1.7b | $16.48 | 0.0% | 8.5K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.7b | $6.18 | 0.0% | 790 |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $1.5b | $32.75 | 0.0% | 607 |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.5b | $27.60 | 0.0% | N/A |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.5b | $11.36 | 0.0% | 18.2K |
 PSNL | Personalis, Inc. Common Stock | Genetic Testing & Diagnostics | $1.4b | $13.44 | 0.0% | 744 |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $1.3b | $30.20 | 0.0% | 111 |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.1b | $5.92 | 0.0% | 243 |